The Access to Medicine Index is a very important project. What gets measured, gets done.
NEW: latest framework for action by pharma companies on access to medicine
The methodology for the 2018 Access to Medicine Index represents the latest good practice framework for pharmaceutical companies working to improve access to medicine. Developed through the Foundation’s consensus-building process, it pinpoints how and where pharmaceutical companies have the greatest potential to make medicine more accessible. It will track how 20 of the world’s largest research-based pharmaceutical companies address these priorities.
News and Events
12 Oct 2017
05 Oct 2017
24 Aug 2017
18 May 2017
21 Apr 2017
06 Mar 2017
13 Dec 2016
Access to medicine: a material issue for investors
Investors engage with the Foundation for insight into our analysis of the pharma sector, including into governance structures, R&D and pricing strategies.
The foundation on Twitter
“To improve access, we believe pharmaceutical companies need to focus on how
they deploy their products, and, as global citizens, collaborate on the development of strong health systems.”
Jayasree K. Iyer, Executive Director, Access to Medicine Foundation.
The Access to Medicine Foundation and its publications are funded by